Baird Medical partner files FDA premarket notification, EU CE conformity application for irreversible electroporation system

Baird Medical Investment Holdings' partner Tianjin Yuanshan Medical Technology has filed a premarket notification with the FDA and an application for CE conformity assessment in the EU for its irreversible electroporation system.

Detected & updated continuously · Source: Nebula

Story subjects

Baird Medical Investment Holdings Ltd Ordinary ShareTianjin Yuanshan Medical TechnologyFood and Drug Administration

Track sentiment and mindshare across stocks and crypto in Nebula.

Open Nebula